Breaking News
Get 50% Off 0
Top 10 Stocks Best Positioned to Break Out This Earnings Season
See the List
Close

Guilin Sanjin Pharmaceutical Co Ltd (002275)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
15.08 +0.06    +0.40%
04:29:54 - Delayed Data. Currency in CNY
Type:  Equity
Market:  China
ISIN:  CNE100000DY9 
  • Volume: 3,214,778
  • Bid/Ask: 15.08 / 15.09
  • Day's Range: 14.96 - 15.25
Guilin Sanjin A 15.08 +0.06 +0.40%

Guilin Sanjin Pharmaceutical Co Ltd Company Profile

 
Get an in-depth profile of Guilin Sanjin Pharmaceutical Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

2720

Equity Type

ORD

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China. The company primarily offers Guilin watermelon frost and lozenge, and Sanjin tablets under the Chinese TCM brand; and Naomaitai capsules, etc. It also produces TCM preparations. Guilin Sanjin Pharmaceutical Co., Ltd. was founded in 1967 and is headquartered in Guilin, China. Guilin Sanjin Pharmaceutical Co., Ltd. operates as a subsidiary of Guilin SanJin Group Co.,Ltd.

Contact Information

Address No.1, Gold Star(Jinxing) Road
Guilin,
China
Phone 86 77 3584 3251
Fax 86 77 3584 3251

Top Executives

Name Age Since Title
Xun Zou 48 2010 Chairman of the Board & President
Yuangang Xie 63 2007 VP, CFO & Director
Zhun Zou 44 2013 VP & Non-Independent Director
Zhongyang Yang 56 2013 Chairman of the Supervisory Board
Jingdu Lei 54 2022 Director & VP
Huanfeng Liu 63 2023 Independent Director
Liping Fu 52 2019 Director
Liwen He 46 2019 Independent Director
Jinqian Xu 54 2022 Personnel Administration Director, Manager of HR Mgmt. Dept. & Director
Ruizhi Wang 51 2019 Director of the Lean Management Office & Employee Supervisor
Zhiyu Wu 54 2022 Non-Employee Supervisor
Huanfeng Liu 63 2015 Independent Director
Lingxia Mo 61 2019 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

002275 Comments

Write your thoughts about Guilin Sanjin Pharmaceutical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email